Tavistock Life Sciences, Shareholder at Mirati Therapeutics, holds 58.40M shares in Mirati Therapeutics (Ticker: MRTX), holds 5.71M shares in PsyBio Therapeutics (Ticker: TSE:PSYB.H), holds 2.47M shares in HLS Therapeutics Inc (Ticker: TSE:HLS). Most recently, Tavistock Life Sciences ― shares of Mirati Therapeutics on ― for an estimated value of ―.
What was Tavistock Life Sciences’s latest transaction?
Tavistock Life Sciences latest transaction was an Uninformative Buy of ―.
What was Tavistock Life Sciences's most profitable transaction?
Tavistock Life Sciences’s most profitable transaction was an Informative Buy of BLU stock on May 13, 2019. The return on the trade was 183.70%.
What is Tavistock Life Sciences's role in Mirati Therapeutics?
Tavistock Life Sciences's role in Mirati Therapeutics is Shareholder.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.